Status:
ACTIVE_NOT_RECRUITING
Evaluation of Improved Onboard Patient Imaging
Lead Sponsor:
Varian, a Siemens Healthineers Company
Conditions:
Head and Neck Cancer
Breast Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of radiation therapy is to deliver a therapeutic dose of radiation precisely to the target while minimizing exposure to healthy surrounding tissues. Image-guided radiation therap...
Eligibility Criteria
Inclusion
- Patient is willing and able to provide written consent.
- Patient is at least 18 years of age at the time of consent.
- Patient has biopsy confirmed malignancy and recommendation for definitive or palliative radiation to the head and neck, breast, lungs, upper GI structures, or pelvis.
- Patient has ECOG performance status 0-2.
- Patient will be receiving radiation therapy at University of Maryland Medical Center, Department of Radiation Oncology.
Exclusion
- Patient is pregnant or attempting pregnancy.
- Patient has known genetic pre-disposition for sensitivity to radiation (e.g., Li Fraumeni).
- Patient receives palliative radiation for 5 or fewer fractions.
- Patient is part of a vulnerable population (per ISO 14155:2020, "individuals who are unable to fully understand all aspects of the investigation that are relevant to the decision to participate, or who could be manipulated or unduly influenced as a result of a compromised position, expectation of benefits or fear of retaliatory response"). This includes prisoners.
Key Trial Info
Start Date :
July 10 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06187103
Start Date
July 10 2024
End Date
December 1 2026
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Maryland Medical Center
Baltimore, Maryland, United States, 21201-1544